Aida Pharmaceuticals, Inc. (AIDA)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Aug 5, 2025
Aida Pharmaceuticals Revenue
Aida Pharmaceuticals had revenue of $11.89M in the quarter ending September 30, 2008, with 61.19% growth. This brings the company's revenue in the last twelve months to $40.51M, up 41.27% year-over-year. In the year 2007, Aida Pharmaceuticals had annual revenue of $29.20M, down -1.48%.
Revenue (ttm)
40.51M
Revenue Growth
+41.27%
P/S Ratio
0.00
Revenue / Employee
90.01K
Employees
450
Market Cap
5.40K
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2007 | 29.20M | -439.32K | -1.48% |
Dec 31, 2006 | 29.64M | 5.12M | 20.86% |
Dec 31, 2005 | 24.53M | 8.88M | 56.77% |
Dec 31, 2004 | 15.65M | 3.06M | 24.27% |
Dec 31, 2003 | 12.59M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 105.45M |
Glass House Brands | 221.55M |
American Oncology Network | 1.76B |
Northwest Biotherapeutics | 1.09M |
Silence Therapeutics | 27.17M |
Global Cord Blood | 196.10M |